Xylem (XYL)
(Delayed Data from NYSE)
$134.39 USD
-0.64 (-0.47%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $134.42 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$134.39 USD
-0.64 (-0.47%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $134.42 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Zacks News
Xylem (XYL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want Better Returns? Don?t Ignore These 2 Industrial Products Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Chart Industries (GTLS) Moves 8.1% Higher: Will This Strength Last?
by Zacks Equity Research
Chart Industries (GTLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Griffon (GFF) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Griffon's (GFF) Q1 results are likely to gain from strength in the HBP segment. However, weakness in the CPP segment, along with higher marketing costs, is expected to have hurt its performance.
Honeywell (HON) Gears Up to Post Q4 Earnings: What to Expect?
by Zacks Equity Research
Honeywell's (HON) fourth-quarter results are likely to have benefited from strength across its businesses. Weakness in the warehouse automation market and high costs and expenses might have been spoilsports.
Parker-Hannifin (PH) to Post Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Parker-Hannifin's (PH) fiscal second quarter performance is expected to have gained from solid demand for its products across the oil & gas, material handling, farm and agriculture end markets.
Will Xylem (XYL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Xylem (XYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Xylem (XYL) Gains From Business Strength, Risks Persist
by Zacks Equity Research
Xylem (XYL) benefits from growth in the utilities and industrial end markets, along with the acquisition of Evoqua. However, rising operating costs and expenses might dent its margins.
Should You Invest in the Invesco S&P Global Water Index ETF (CGW)?
by Zacks Equity Research
Sector ETF report for CGW
The Zacks Analyst Blog Highlights NVIDIA, Oracle, The TJX Companies, Chubb and Xylem
by Zacks Equity Research
NVIDIA, Oracle, The TJX Companies, Chubb and Xylem are part of the Zacks top Analyst Blog .
Top Stock Reports for NVIDIA, Oracle & The TJX Companies
by Mark Vickery
Toda's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Oracle Corporation (ORCL) and The TJX Companies, Inc. (TJX).
Here's Why Investing in Xylem (XYL) Stock Makes Sense Now
by Zacks Equity Research
Xylem (XYL) benefits from strength in the Measurement & Control Solutions segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.
Manufacturing Activity Poised for Rebound in 2024: 5 Picks
by Ritujay Ghosh
Stocks like Eaton Corporation (ETN), A. O. Smith Corporation (AOS), Xylem (XYL), Graham Corporation (GHM) and Applied Industrial Technologies (AIT) are poised to benefit from the jump in durable goods orders.
Buy 5 Manufacturing Stocks Despite Disappointing November PMI
by Nalak Das
We have narrowed our search to five manufacturing stocks with strong potential for 2024. These are: EMR, ETN, AMCR, XYL, AOS.
What Makes Xylem (XYL) a New Buy Stock
by Zacks Equity Research
Xylem (XYL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
If You Invested $1000 in Xylem a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Xylem (XYL) Up 9.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold on to Xylem (XYL) Stock Right Now
by Zacks Equity Research
Strength in the Measurement & Control Solutions segment and the acquisition of Evoqua bode well for Xylem (XYL). The company's measures to reward its shareholders are encouraging.
Xylem (XYL) Recently Broke Out Above the 200-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Here's How Much a $1000 Investment in Xylem Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Xylem (XYL) Q3 Earnings & Revenues Beat, '23 View Upbeat
by Zacks Equity Research
Xylem's (XYL) Q3 results benefit from strong commercial and operational execution and resilient demand. The company improves its 2023 guidance.
Compared to Estimates, Xylem (XYL) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Xylem (XYL) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 11.24% and 4.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the Invesco S&P Global Water Index ETF (CGW)?
by Zacks Equity Research
Sector ETF report for CGW
Ingersoll Rand (IR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ingersoll (IR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.